Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0001209191-23-046512

Secretary, Treasurer & CFO sold 22,683 shares at $28.59 ($648,455)

  • Secretary, Treasurer & CFO gave up 22,311 shares (to pay taxes)
  • Secretary, Treasurer & CFO acquired 44,994 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

STEPHENSON BRIAN C · Secretary, Treasurer & CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Exercise or conversion : show line 1 in the form 10b5-1 +44,994 81,704 D
2023-08-16 Shares withheld for taxes : show line 2 in the form 10b5-1 −22,311 $29.80 $664,868 59,393 D
2023-08-17 Sale : show line 3 in the form 10b5-1 −22,683 $28.59 $648,455 36,710 D
Open-market sales · 22,683 sh · avg $28.59 · $648,455

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2023-08-16 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units −1,709 5,130 D
2023-08-16 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Units −778 4,669 D
2023-08-16 Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Units −24,193 48,386 D
2023-08-16 Exercise or conversion : show line 7 in the form 10b5-1 Restricted Stock Units −946 8,519 D
2023-08-16 Exercise or conversion : show line 8 in the form 10b5-1 Restricted Stock Units −17,368 243,157 D
Loading xslF345X05/doc4.xml…